Literature DB >> 10867646

Integrin involvement in glioblastoma multiforme: possible regulation by NF-kappaB.

C K Ritchie1, A Giordano, K Khalili.   

Abstract

Glioblastoma multiforme (GBM) is the most malignant astroglial-derived tumors which has the propensity to aggressively infiltrate normal regions of the brain surrounding the tumor. The interaction of tumor cells with the extracellular matrix (ECM) is an integral step in the process of tumorigenesis and may play a role in the local invasion of the GBM cells. Our study investigated the role of the nuclear transcription factor NF-kappaB on GBM integrin expression and cell attachment. Our results show that treatment of GBM cell lines, SNB-19 and T98G with PMA, an inducer of NF-kappaB, increased the expression of fibronectin and vitronectin genes. Accordingly, ectopic over-expression of NFkappaB subunits in GBM cells elevated the levels of fibronectin gene expression, providing direct evidence for a regulatory role for NF-kappaB in ECM protein production. Cell attachment to the ECM proteins including fibronectin, vitronectin and laminin was increased in GBM and normal astrocytic cells. Interestingly, treatment of cells with PMA augmented attachment of SNB-19 and T98G cells to fibronectin and vitronectin, however it had no effect on attachment of normal astrocytes. Addition of the tripeptide arginine-glycine-asparatic acid (RGD), the recognition site for many integrins, significantly inhibited SNB-19 and T98G cell attachment to fibronectin and vitronectin. Finally, activation of NFkappaB upon treatment of SNB cells with PMA led to an increase in the levels of mRNA for the beta3 and the alphav integrin subunits. Collectively, these data demonstrate a possible role for NF-kappaB in glioma cell attachment. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10867646     DOI: 10.1002/1097-4652(200008)184:2<214::AID-JCP9>3.0.CO;2-Z

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  12 in total

Review 1.  The role of alpha(v)beta(3) in prostate cancer progression.

Authors:  Carlton R Cooper; Christopher H Chay; Kenneth J Pienta
Journal:  Neoplasia       Date:  2002 May-Jun       Impact factor: 5.715

2.  Identification of gene function and functional pathways by systemic plasmid-based ribozyme targeting in adult mice.

Authors:  Mohammed Kashani-Sabet; Yong Liu; Sylvia Fong; Pierre-Yves Desprez; Shuqing Liu; Guanghuan Tu; Mehdi Nosrati; Chakkrapong Handumrongkul; Denny Liggitt; Ann D Thor; Robert J Debs
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-12       Impact factor: 11.205

3.  Expression of nuclear factor-kappa B in hepatocellular carcinoma and its relation with the X protein of hepatitis B virus.

Authors:  S P Guo; W L Wang; Y Q Zhai; Y L Zhao
Journal:  World J Gastroenterol       Date:  2001-06       Impact factor: 5.742

4.  Aberrant constitutive activation of nuclear factor kappaB in glioblastoma multiforme drives invasive phenotype.

Authors:  Baisakhi Raychaudhuri; Yulong Han; Tao Lu; Michael A Vogelbaum
Journal:  J Neurooncol       Date:  2007-05-04       Impact factor: 4.130

5.  Suppression of the proliferation of human U-87 MG glioblastoma cells by new antagonists of growth hormone-releasing hormone in vivo and in vitro.

Authors:  Miklos Jaszberenyi; Andrew V Schally; Norman L Block; Marta Zarandi; Ren-Zhi Cai; Irving Vidaurre; Luca Szalontay; Arumugam R Jayakumar; Ferenc G Rick
Journal:  Target Oncol       Date:  2013-02-01       Impact factor: 4.493

6.  Human cytomegalovirus induces cellular tyrosine kinase signaling and promotes glioma cell invasiveness.

Authors:  Charles S Cobbs; Liliana Soroceanu; Scott Denham; Wenyue Zhang; William J Britt; Russ Pieper; Matthias H Kraus
Journal:  J Neurooncol       Date:  2007-06-23       Impact factor: 4.130

7.  IIp45, an insulin-like growth factor binding protein 2 (IGFBP-2) binding protein, antagonizes IGFBP-2 stimulation of glioma cell invasion.

Authors:  Sonya W Song; Gregory N Fuller; Asadullah Khan; Shouming Kong; Weiping Shen; Ellen Taylor; Latha Ramdas; Frederick F Lang; Wei Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-14       Impact factor: 11.205

8.  Potentiation of cytotoxic chemotherapy by growth hormone-releasing hormone agonists.

Authors:  Miklos Jaszberenyi; Ferenc G Rick; Petra Popovics; Norman L Block; Marta Zarandi; Ren-Zhi Cai; Irving Vidaurre; Luca Szalontay; Arumugam R Jayakumar; Andrew V Schally
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-30       Impact factor: 11.205

Review 9.  The functions and applications of RGD in tumor therapy and tissue engineering.

Authors:  Fen Wang; Yuanyuan Li; Yingqiang Shen; Anming Wang; Shuling Wang; Tian Xie
Journal:  Int J Mol Sci       Date:  2013-06-27       Impact factor: 5.923

10.  Short hairpin RNA-mediated fibronectin knockdown delays tumor growth in a mouse glioma model.

Authors:  Sadhak Sengupta; Suvobroto Nandi; Enal S Hindi; Derek A Wainwright; Yu Han; Maciej S Lesniak
Journal:  Neoplasia       Date:  2010-10       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.